372 related articles for article (PubMed ID: 15842509)
21. Comparison of different vascular risk engines in the identification of type 2 diabetes patients with high cardiovascular risk.
Rodriguez-Poncelas A; Coll-de-Tuero G; Saez M; Garrido-MartÃn JM; Millaruelo-Trillo JM; Barrot de-la-Puente J; Franch-Nadal J;
BMC Cardiovasc Disord; 2015 Oct; 15():121. PubMed ID: 26464076
[TBL] [Abstract][Full Text] [Related]
22. Cardiovascular risk prediction in a population with the metabolic syndrome: Framingham vs. UKPDS algorithms.
Zomer E; Liew D; Owen A; Magliano DJ; Ademi Z; Reid CM
Eur J Prev Cardiol; 2014 Mar; 21(3):384-90. PubMed ID: 22588087
[TBL] [Abstract][Full Text] [Related]
23. Relation between age and coronary heart disease (CHD) risk in Asian Indian patients with diabetes: A cross-sectional and prospective cohort study.
Idris I; Deepa R; Fernando DJ; Mohan V
Diabetes Res Clin Pract; 2008 Aug; 81(2):243-9. PubMed ID: 18495288
[TBL] [Abstract][Full Text] [Related]
24. Comparative performance of diabetes-specific and general population-based cardiovascular risk assessment models in people with diabetes mellitus.
Echouffo-Tcheugui JB; Kengne AP
Diabetes Metab; 2013 Oct; 39(5):389-96. PubMed ID: 24080092
[TBL] [Abstract][Full Text] [Related]
25. Metabolic syndrome vs Framingham Risk Score for prediction of coronary heart disease, stroke, and type 2 diabetes mellitus.
Wannamethee SG; Shaper AG; Lennon L; Morris RW
Arch Intern Med; 2005 Dec 12-26; 165(22):2644-50. PubMed ID: 16344423
[TBL] [Abstract][Full Text] [Related]
26. A pen-and-paper coronary risk estimator for office use with patients with type 2 diabetes.
Christianson TJ; Bryant SC; Weymiller AJ; Smith SA; Montori VM
Mayo Clin Proc; 2006 May; 81(5):632-6. PubMed ID: 16706261
[TBL] [Abstract][Full Text] [Related]
27. Preventable coronary heart disease events from control of cardiovascular risk factors in US adults with diabetes (projections from utilizing the UKPDS risk engine).
Wong ND; Patao C; Malik S; Iloeje U
Am J Cardiol; 2014 Apr; 113(8):1356-61. PubMed ID: 24581920
[TBL] [Abstract][Full Text] [Related]
28. Performance of the UK Prospective Diabetes Study Risk Engine and the Framingham Risk Equations in Estimating Cardiovascular Disease in the EPIC- Norfolk Cohort.
Simmons RK; Coleman RL; Price HC; Holman RR; Khaw KT; Wareham NJ; Griffin SJ
Diabetes Care; 2009 Apr; 32(4):708-13. PubMed ID: 19114615
[TBL] [Abstract][Full Text] [Related]
29. The UKPDS risk engine: a model for the risk of coronary heart disease in Type II diabetes (UKPDS 56).
Stevens RJ; Kothari V; Adler AI; Stratton IM;
Clin Sci (Lond); 2001 Dec; 101(6):671-9. PubMed ID: 11724655
[TBL] [Abstract][Full Text] [Related]
30. Estimation of 10-Year Risk of Coronary Heart Disease in Nepalese Patients with Type 2 Diabetes: Framingham Versus United Kingdom Prospective Diabetes Study.
Pokharel DR; Khadka D; Sigdel M; Yadav NK; Sapkota LB; Kafle R; Nepal S; Sapkota RM; Choudhary N
N Am J Med Sci; 2015 Aug; 7(8):347-55. PubMed ID: 26417557
[TBL] [Abstract][Full Text] [Related]
31. Factors predicting the development of metabolic syndrome and type II diabetes against a background of hypertension.
Lim HS; Lip GY; Beevers DG; Blann AD
Eur J Clin Invest; 2005 May; 35(5):324-9. PubMed ID: 15860044
[TBL] [Abstract][Full Text] [Related]
32. Cardiovascular risk assessment in type 2 diabetes mellitus: comparison of the World Health Organization/International Society of Hypertension risk prediction charts versus UK Prospective Diabetes Study risk engine.
Herath HM; Weerarathna TP; Umesha D
Vasc Health Risk Manag; 2015; 11():583-9. PubMed ID: 26622181
[TBL] [Abstract][Full Text] [Related]
33. The Framingham and UK Prospective Diabetes Study (UKPDS) risk equations do not reliably estimate the probability of cardiovascular events in a large ethnically diverse sample of patients with diabetes: the Action in Diabetes and Vascular Disease: Preterax and Diamicron-MR Controlled Evaluation (ADVANCE) Study.
Kengne AP; Patel A; Colagiuri S; Heller S; Hamet P; Marre M; Pan CY; Zoungas S; Grobbee DE; Neal B; Chalmers J; Woodward M;
Diabetologia; 2010 May; 53(5):821-31. PubMed ID: 20157695
[TBL] [Abstract][Full Text] [Related]
34. Impact of impaired fasting glucose on cardiovascular disease: the Framingham Heart Study.
Levitzky YS; Pencina MJ; D'Agostino RB; Meigs JB; Murabito JM; Vasan RS; Fox CS
J Am Coll Cardiol; 2008 Jan; 51(3):264-70. PubMed ID: 18206734
[TBL] [Abstract][Full Text] [Related]
35. Skin autofluorescence provides additional information to the UK Prospective Diabetes Study (UKPDS) risk score for the estimation of cardiovascular prognosis in type 2 diabetes mellitus.
Lutgers HL; Gerrits EG; Graaff R; Links TP; Sluiter WJ; Gans RO; Bilo HJ; Smit AJ
Diabetologia; 2009 May; 52(5):789-97. PubMed ID: 19274450
[TBL] [Abstract][Full Text] [Related]
36. Assessment of cardiovascular risk in adults with type 2 diabetes and metabolic syndrome: Framingham versus UKPDS equations.
Kim CJ; Kang HS; Schlenk EA; Chae SM
Diabetes Educ; 2015 Apr; 41(2):203-13. PubMed ID: 25699567
[TBL] [Abstract][Full Text] [Related]
37. Prognostic significance of silent myocardial infarction in newly diagnosed type 2 diabetes mellitus: United Kingdom Prospective Diabetes Study (UKPDS) 79.
Davis TM; Coleman RL; Holman RR;
Circulation; 2013 Mar; 127(9):980-7. PubMed ID: 23362315
[TBL] [Abstract][Full Text] [Related]
38. Predictive value for the Chinese population of the Framingham CHD risk assessment tool compared with the Chinese Multi-Provincial Cohort Study.
Liu J; Hong Y; D'Agostino RB; Wu Z; Wang W; Sun J; Wilson PW; Kannel WB; Zhao D
JAMA; 2004 Jun; 291(21):2591-9. PubMed ID: 15173150
[TBL] [Abstract][Full Text] [Related]
39. Performance of Framingham cardiovascular disease (CVD) predictions in the Rotterdam Study taking into account competing risks and disentangling CVD into coronary heart disease (CHD) and stroke.
van Kempen BJ; Ferket BS; Kavousi M; Leening MJ; Steyerberg EW; Ikram MA; Witteman JC; Hofman A; Franco OH; Hunink MG
Int J Cardiol; 2014 Feb; 171(3):413-8. PubMed ID: 24438922
[TBL] [Abstract][Full Text] [Related]
40. Impact of metabolic surgery on 10-year cardiovascular disease risk in Chinese individuals with type 2 diabetes.
Ke Z; Li F; Zhou X; Sun F; Zhu Z; Tong W
Surg Obes Relat Dis; 2021 Mar; 17(3):498-507. PubMed ID: 33358863
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
